Guest: J. Kevin Harrison, MD

CME Information FacultyJ. Kevin Harrison, MDProfessor of MedicineInterventional Director, Duke Center for Structural Heart DiseaseDuke University Health SystemDurham, NC Activity PlannersJulie Blum, PhDClinical Content ManagerMed-IQBaltimore, MD Rebecca L. Julian, MS, ELSSenior Managing EditorMed-IQBaltimore, MD Amy SisonDirector of Continuing Medical EducationMed-IQBaltimore, MD WriterAnne Jacobson, MPHPort St. John, FL Activity OverviewThis activity discusses valve replacement strategies, including guideline recommendations, risks, and benefits of such strategies in cardiac patients. Learning ObjectivesUpon completion, participants should be able to: Describe the differences in general criteria for TAVR and SAVR Understand the risks and benefits of available devices and how using these devices compares with standard medical therapy Target AudienceThis activity is intended for cardiologists. Statement of NeedValvular aortic stenosis (AS) is a progressive disease caused by calcification of the aortic valve, with underlying pathophysiologic processes similar to those of atherosclerosis. The prevalence of moderate or severe AS increases with advancing age and currently affects approximately 3% of individuals aged 75 years or older. Although asymptomatic AS does not increase the risk of death, patient prognosis deteriorates substantially once the disease becomes symptomatic. In this activity, recent clinical trial evidence and updated guidelines are presented to ensure that clinicians are making proper treatment decisions for their ...